Researchers developed a saliva based SERS platform that detects epilepsy, Parkinson's disease, and schizophrenia by analyzing protein structural changes with up to 98% accuracy.
Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.
Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results